SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 73 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $140,000 | +19.7% | 46,568 | -2.8% | 0.00% | – |
Q1 2015 | $117,000 | -13.3% | 47,925 | -9.4% | 0.00% | – |
Q4 2014 | $135,000 | -69.5% | 52,923 | -14.7% | 0.00% | -100.0% |
Q3 2014 | $443,000 | +11.9% | 62,037 | +2.2% | 0.00% | 0.0% |
Q2 2014 | $396,000 | +17.2% | 60,675 | +18.5% | 0.00% | 0.0% |
Q1 2014 | $338,000 | +122.4% | 51,182 | +59.6% | 0.00% | – |
Q4 2013 | $152,000 | -2.6% | 32,072 | +2.1% | 0.00% | – |
Q3 2013 | $156,000 | – | 31,419 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |